- active not recruitingPHASE1
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
This study is testing a new cancer medicine, botensilimab, sometimes with another drug, balstilimab. It's for people with advanced cancers that haven't responded to other treatments. Doctors want to see if it's safe, how it works, and find the best dose.
United States · United Kingdom - recruiting
Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
This study looks at how new ways to treat high-risk sarcoma, a type of cancer, can be made more personal. Researchers are collecting information and samples from patients to find the best treatments before surgery, aiming for better results.
United Kingdom